FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Tice

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Disorders

Breast Neoplasms

Phenomena

Physiology

Signal Transduction

Co-author Network

Publications

TOP 3
Zhan Xiao; Rosa Carrasco; Steven R Coats; Bahija Jallal; Krista L Kinneer; Darrin Sabol; David A Tice
EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target.
Stergios J Moschos; Cindy A Sander; Wenjun Wang; Shelley L Reppert; Laura M Drogowski; Drazen M Jukic; Uma N M Rao; Charalambos Athanassiou; Manuela Buzoianu; Maja Mandic; Laura K Richman; LuAnn McKinney; Joel Leininger; David A Tice; Luz D Hammershaimb; John M Kirkwood
Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma.
Tae Jin Kim; Charles N Landen; Yvonne G Lin; Lingegowda S Mangala; Chunhua Lu; Alpa M Nick; Rebecca L Stone; William M Merritt; Guillermo Armaiz-Pena; Nicholas B Jennings; Robert L Coleman; David A Tice; Anil K Sood
Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Tice (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Zhan Xiao; Rosa Carrasco; Steven R Coats; Bahija Jallal; Krista L Kinneer; Darrin Sabol; David A Tice
EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target.
Cancer biology & therapy 2012;13(8):630-7.
2010: Stergios J Moschos; Cindy A Sander; Wenjun Wang; Shelley L Reppert; Laura M Drogowski; Drazen M Jukic; Uma N M Rao; Charalambos Athanassiou; Manuela Buzoianu; Maja Mandic; Laura K Richman; LuAnn McKinney; Joel Leininger; David A Tice; Luz D Hammershaimb; John M Kirkwood
Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(3):316-25.
2009: Tae Jin Kim; Charles N Landen; Yvonne G Lin; Lingegowda S Mangala; Chunhua Lu; Alpa M Nick; Rebecca L Stone; William M Merritt; Guillermo Armaiz-Pena; Nicholas B Jennings; Robert L Coleman; David A Tice; Anil K Sood
Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer.
Cancer biology & therapy 2009;8(23):2263-72.
2009: Jeong-Won Lee; Hee Dong Han; Mian Shahzad; Seung Wook Kim; Lingegowda S Mangala; Alpa M Nick; Chunhua Lu; Robert R Langley; Rosemarie Schmandt; Hye-Sun Kim; Shenlan Mao; John Gooya; Christine A Fazenbaker; Dowdy Jackson; David A Tice; Charles N Landen; Robert L Coleman; Anil K Sood
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.
Journal of the National Cancer Institute 2009;101(17):1193-205.
2008: Dowdy Jackson; John Gooya; Shenlan Mao; Krista L Kinneer; Linda Xu; Margarita Camara; Christine A Fazenbaker; Ryan Fleming; Sudha Swamynathan; Damon Meyer; Peter D Senter; Changshou Gao; Herren Wu; Michael S Kinch; Steven R Coats; Peter Kiener; David A Tice
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.
Cancer research 2008;68(22):9367-74.
2008: Charles N Landen; Tae-Jin Kim; Yvonne G Lin; William M Merritt; Aparna A Kamat; Liz Y Han; Whitney A Spannuth; Alpa M Nick; Nicholas B Jennnings; Michael S Kinch; David A Tice; Anil K Sood
Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.
Neoplasia (New York, N.Y.) 2008;10(11):1259-67.
2007: Weibo Cai; Alireza Ebrahimnejad; kai chen; Qizhen Cao; Zi-Bo Li; David A Tice; Xiaoyuan Chen
Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice.
European journal of nuclear medicine and molecular imaging 2007;34(12):2024-36.
2006: Kathy A Mulgrew; Krista L Kinneer; Xiao-Tao Yao; Beth K Ward; Melissa M Damschroder; Bill Walsh; Su-Yau Mao; Changshou Gao; Peter Kiener; Steven R Coats; Michael S Kinch; David A Tice
Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin.
Molecular cancer therapeutics 2006;5(12):3122-9.
2006: Weibo Cai; Yun Wu; kai chen; Qizhen Cao; David A Tice; Xiaoyuan Chen
In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
Cancer research 2006;66(19):9673-81.
2004: Dolores Grosso; Joanne Filicko; Guillermo Garcia-Manero; Frank Beardell; Janet Brunner; Jeffrey Cohn; Andres Ferbér; José Martinez; Bijoyesh Mookerjee; Lewis Rose; David A Tice; John L Wagner; Robert Capizzi; Neal Flomenberg
Cytoprotection in acute myelogenous leukemia (AML) therapy.
Seminars in oncology 2004;31(6 Suppl 18):67-73.
2004: Rumey C Ishizawar; David A Tice; Themistoclis Karaoli; Sarah J Parsons
The C terminus of c-Src inhibits breast tumor cell growth by a kinase-independent mechanism.
The Journal of biological chemistry 2004;279(22):23773-81.
2003: Karen Coffman; Min Hu; Kelly L Carles-Kinch; David A Tice; Nanci E Donacki; Karyn Munyon; Gizachew Kifle; Robert M Woods; Solomon Langermann; Peter Kiener; Michael S Kinch
Differential EphA2 epitope display on normal versus malignant cells.
Cancer research 2003;63(22):7907-12.
2002: David A Tice; Wayne Szeto; Irina Soloviev; Bonnee Rubinfeld; Sharon E Fong; Debra L Dugger; Jane Winer; P Mickey Williams; David Wieand; Victoria Smith; Ralph Schwall; Diane Pennica; Paul Polakis
Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling.
The Journal of biological chemistry 2002;277(16):14329-35.
2002: David A Tice; Irina Soloviev; Paul Polakis
Activation of the Wnt pathway interferes with serum response element-driven transcription of immediate early genes.
The Journal of biological chemistry 2002;277(8):6118-23.
2001: Bonnee Rubinfeld; David A Tice; Paul Polakis
Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon.
The Journal of biological chemistry 2001;276(42):39037-45.
2001: W Szeto; W Jiang; David A Tice; Bonnee Rubinfeld; P G Hollingshead; Sharon E Fong; D L Dugger; Thinh Pham; Daniel G Yansura; T A Wong; J C Grimaldi; Racquel Corpuz; J S Singh; Gretchen D Frantz; B Devaux; Craig W Crowley; Ralph Schwall; David A Eberhard; L Rastelli; Paul Polakis; Diane Pennica
Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid.
Cancer research 2001;61(10):4197-205.
2001: A P Belsches-Jablonski; Jacqueline S Biscardi; D R Peavy; David A Tice; D A Romney; Sarah J Parsons
Src family kinases and HER2 interactions in human breast cancer cell growth and survival.
Oncogene 2001;20(12):1465-75.
1999: Jacqueline S Biscardi; Ming-Chei Maa; David A Tice; Michael E Cox; Tzeng-Horng Leu; Sarah J Parsons
c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function.
The Journal of biological chemistry 1999;274(12):8335-43.
1999: David A Tice; Jacqueline S Biscardi; A L Nickles; Sarah J Parsons
Mechanism of biological synergy between cellular Src and epidermal growth factor receptor.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(4):1415-20.
1999: Jacqueline S Biscardi; David A Tice; Sarah J Parsons
c-Src, receptor tyrosine kinases, and human cancer.
Advances in cancer research 1999;76():61-119.
1997: M F Ware; David A Tice; Sarah J Parsons; Douglas A Lauffenburger
Overexpression of cellular Src in fibroblasts enhances endocytic internalization of epidermal growth factor receptor.
The Journal of biological chemistry 1997;272(48):30185-90.